A specialist from Oman, located at the crossroads of Africa and Asia, explains that his nation serves as a microcosm when it ...
Zydus Lifesciences announced a significant development for beta-thalassemia patients. The US Food and Drug Administration has ...
Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay ...
Vertex Pharmaceuticals reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer ...
said Joanne Lager, MD, Chief Medical Officer. "The presentation highlights the growing demand for ZYNTEGLO, the first FDA-approved gene therapy for eligible patients with transfusion-dependent ...